Ozempic, Wegovy and Mounjaro are among the weight-loss drugs that more people are taking - but questions have been raised about their economic impacts.
These drugs will also have an impact on other sectors, including healthcare and food, and research is still ongoing.
Fisher Funds expert Sam Dickie explained further.
LISTEN ABOVE

Sam Dickie: Fisher Funds expert on Micron unveiling their third-quarter earnings
03:01

Wayne Langford: former Federated Farmers president on Colin Hurst taking over his role
03:38

Simon Bridges: Auckland Business Chamber CEO on the 12th annual China Business Summit taking place in Auckland
04:23